Menu
  • Join
  • Login
  • Contact
 

Search abstracts


DESIGN OF ANDROGEN RECEPTOR INHIBITORS USING EXPERIMENTAL (S)-11 AND (R)-9 AS LEADS

  • At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
  • Type: Poster
  • By: SHOEMAKE, Claire (University of Malta, Pharmacy, Malta)
  • Co-author(s): Simona Neykova: Pharmacy, University of Malta, Msida, Malta
    Claire Shoemake: Pharmacy, University of Malta, Msida, Malta
  • Abstract:

    Background

    Treatment of prostate cancer relies on Androgen deprivation/Androgen Receptor (AR) inhibition. AR mutation causes the condition to become refractory. Literature shows that the Small Androgen Receptor Modulators (SARMs) (R)-9 and (S)-11 are anti-androgens with AR mutant inhibition capability making them viable leads for the management of..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses